naltrexone and butorphanol

naltrexone has been researched along with butorphanol in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (10.87)	18.7374
1990's	17 (36.96)	18.2507
2000's	13 (28.26)	29.6817
2010's	8 (17.39)	24.3611
2020's	3 (6.52)	2.80

Authors

Authors	Studies
Bousquet, AR; Howes, JF; Kotick, MP; Polazzi, JO	1
Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Bidlack, JM; Bu, Y; Cohen, DJ; Lou, R; Lu, Q; VanAlstine, MA; Wentland, MP	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW	2
Dykstra, LA	1
Cho, TM; Nozaki, M	1
Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM	1
Hameroff, SR	1
Billington, CJ; Grace, M; Levine, AS; Portoghese, PS	1
Amundsen, L; Binstock, W; Cox, SM; Faure, EA; Glosten, B; Hibbard, J; Ismail, M; Moawad, AH; Senal, JA; Wittels, B	1
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M	1
Ho, IK; Hoskins, B; Jaw, SP	2
Brandt, MR; France, CP	1
Feng, YZ; Ho, IK; Rockhold, RW; Tokuyama, S; Zhang, T; Zhu, H	1
Ho, IK; Hoshi, K; Ma, T; Oh, S	1
Barton, C; Bray, GA; Ookuma, K; York, DA	1
Burke, TF; Garner, HR; Lawhorn, CD; Stoner, JM; Wessinger, WD	1
Feng, Y; Ho, IK; Rockhold, RW	1
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W	1
Butelman, ER; Ko, MC; Mosberg, HI; Sobczyk-Kojiro, K; Van Bemmel, B; Woods, JH; Zernig, G	1
Morgan, D; Picker, MJ	1
Aguilar, R; Bailey, JE; Foerster, CR; Foerster, SH; Loria, DL	1
Childs, SE; Ferrell, ST; Radcliffe, RW	1
Hendrickson, DA; Radcliffe, RM; Radcliffe, RW; Richardson, GL; Zuba, JR	1
Billington, CJ; Grace, MK; Jewett, DC; Jones, RM; Levine, AS; Portoghese, PS	1
Ho, IK; Rockhold, RW; Sinchaisuk, S	1
David Clark, J; Demirci, H; Gharagozlou, P; Lameh, J	1
Craft, RM; McNiel, DM	1
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT	1
Spelman, LH	1
Bigelow, GE; Chausmer, AE; Strain, EC; Walsh, SL	1
Calle, PP; Georoff, TA; James, SB; Kalk, P; Martin-Flores, M	1
Li, M; McMillan, DE; Wessinger, WD	1
Anisimova, VA; Grechko, OIu; Spasov, AA	1
Anisimova, VA; Grechko, OIu; Shtareva, DM; Spasov, AA	1
Hayek, LC; Marker, L; Murray, S; Sanchez, CR; Woc Colburn, AM	1
Balhara, YPS; Gupta, R; Sarkar, S; Shah, B	1
Fisher, MC; Mays, T; Miller, MW; Wolfe, LL	1
Gardner, BR; Kotze, PGH; McCue, SA; Musson, M; Seakamela, SM; Spolander, B	1
Anderson, NE; Delnatte, P; Dutton, C; Ferro, A; Larouche, CB; Milnes, EL; Skelding, AM	1

Reviews

2 review(s) available for naltrexone and butorphanol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Opiate receptor pharmacology: mixed agonist/antagonist narcotics. Contemporary anesthesia practice, 1983, Volume: 7 Topics: Analgesics, Opioid; Buprenorphine; Butorphanol; Endorphins; Humans; Nalbuphine; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid	1983

Trials

5 trial(s) available for naltrexone and butorphanol

Article	Year
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesthesia and analgesia, 1993, Volume: 77, Issue:5 Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Butorphanol; Cesarean Section; Female; Humans; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Pregnancy; Prospective Studies	1993
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade. Psychopharmacology, 2008, Volume: 196, Issue:1 Topics: Adult; Affect; Arousal; Butorphanol; Diuresis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Narcotics; Perception; Premedication; Receptors, Opioid, kappa; Receptors, Opioid, mu	2008
Evaluation of medetomidine-ketamine-butorphanol anesthesia with atipamezole-naltrexone antagonism in captive male guanacos (Lama guanicoe). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2010, Volume: 41, Issue:2 Topics: Adrenergic alpha-Antagonists; Anesthetics; Animals; Butorphanol; Camelids, New World; Imidazoles; Ketamine; Male; Medetomidine; Naltrexone; Narcotic Antagonists	2010
CARDIORESPIRATORY EFFECTS OF DEXMEDETOMIDINE-BUTORPHANOL-MIDAZOLAM (DBM): A FULLY REVERSIBLE ANESTHETIC PROTOCOL IN CAPTIVE AND SEMI-FREE-RANGING CHEETAHS (ACINONYX JUBATUS). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2017, Volume: 48, Issue:1 Topics: Acinonyx; Analgesics, Opioid; Anesthesia; Animals; Animals, Zoo; Butorphanol; Dexmedetomidine; Drug Therapy, Combination; Female; Heart Rate; Hypnotics and Sedatives; Imidazoles; Male; Midazolam; Naltrexone; Respiration	2017
A randomized clinical trial to compare ketamine-butorphanol-azaperone-medetomidine and detomidine-etorphine-acepromazine for anesthesia of captive Przewalski horses (Equus przewalskii). American journal of veterinary research, 2022, May-08, Volume: 83, Issue:6 Topics: Acepromazine; Anesthesia; Animals; Azaperone; Butorphanol; Etorphine; Heart Rate; Horses; Hypnotics and Sedatives; Hypoxia; Imidazoles; Immobilization; Ketamine; Medetomidine; Naltrexone; Oxygen; Prospective Studies	2022

Other Studies

39 other study(ies) available for naltrexone and butorphanol

Article	Year
Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Substance Withdrawal Syndrome	1981
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time	1981
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. Bioorganic & medicinal chemistry letters, 2009, Jan-01, Volume: 19, Issue:1 Topics: Amides; Analgesics, Opioid; Humans; Protein Binding; Receptors, Opioid; Structure-Activity Relationship; Tramadol	2009
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Effects of beta-funaltrexamine on butorphanol dependence. Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:1 Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders	1992
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri	1990
Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor. Journal of neurochemistry, 1985, Volume: 45, Issue:2 Topics: Animals; Butorphanol; Cell Membrane; Dihydromorphine; Diprenorphine; Dithionitrobenzoic Acid; Dithiothreitol; Etorphine; Morphine; Nalorphine; Naloxone; Naltrexone; Nitrobenzoates; Oxymorphone; Rats; Receptors, Opioid	1985
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu	1987
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol. European journal of pharmacology, 1994, May-12, Volume: 257, Issue:1-2 Topics: Animals; Butorphanol; Injections, Intraventricular; Male; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders	1994
The effect of selective opioid antagonists on butorphanol-induced feeding. Brain research, 1994, Feb-21, Volume: 637, Issue:1-2 Topics: Animals; Butorphanol; Dose-Response Relationship, Drug; Feeding Behavior; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	1994
Effects of nor-binaltorphimine on butorphanol dependence. European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3 Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor	1993
Opioid antagonists and butorphanol dependence. Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:3 Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome	1993
Involvement of delta-opioid receptors in physical dependence on butorphanol. European journal of pharmacology, 1993, Aug-10, Volume: 240, Issue:1 Topics: Animals; Butorphanol; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance-Related Disorders	1993
Discriminative stimulus effects on enadoline in pigeons. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2 Topics: Animals; Benzofurans; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Dynorphins; Nalbuphine; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa	1996
Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochemical research, 1996, Volume: 21, Issue:1 Topics: Animals; Butorphanol; Drug Evaluation, Preclinical; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Substance Withdrawal Syndrome	1996
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain research, 1997, Apr-04, Volume: 753, Issue:1 Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders	1997
Effect of enterostatin and kappa-opioids on macronutrient selection and consumption. Peptides, 1997, Volume: 18, Issue:6 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Colipases; Dietary Carbohydrates; Dietary Fats; Eating; Enzyme Precursors; Food Preferences; Male; Naltrexone; Narcotic Antagonists; Narcotics; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa	1997
Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Butorphanol; Male; Mice; Morphine; Naltrexone; Pyrrolidines; Receptors, Opioid, mu	1997
Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2 Topics: Animals; Butorphanol; Excitatory Amino Acids; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1997
Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine. Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:3 Topics: Analgesics, Opioid; Animals; Butorphanol; Dose-Response Relationship, Drug; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid	1998
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2 Topics: Analgesics, Opioid; Animals; Benzofurans; Brain Chemistry; Butorphanol; Dose-Response Relationship, Drug; Hot Temperature; Macaca mulatta; Nalbuphine; Naltrexone; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa	1998
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor. Psychopharmacology, 1998, Volume: 140, Issue:1 Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu	1998
Butorphanol/xylazine/ketamine immobilization of free-ranging Baird's tapirs in Costa Rica. Journal of wildlife diseases, 2000, Volume: 36, Issue:2 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Animals, Wild; Blood Gas Analysis; Blood Pressure; Butorphanol; Costa Rica; Electrocardiography; Female; Heart Rate; Immobilization; Ketamine; Male; Naltrexone; Narcotic Antagonists; Oximetry; Perissodactyla; Respiration; Tolazoline; Xylazine; Yohimbine	2000
Butorphanol and azaperone as a safe alternative for repeated chemical restraint in captive white rhinoceros (Ceratotherium simum). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2000, Volume: 31, Issue:2 Topics: Analgesics, Opioid; Anesthetics, Combined; Animals; Azaperone; Butorphanol; Female; Heart Rate; Hypnotics and Sedatives; Immobilization; Injections, Intramuscular; Male; Naltrexone; Oximetry; Perissodactyla	2000
Standing laparoscopic-guided uterine biopsy in a southern white rhinoceros (Ceratotherium simum simum). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2000, Volume: 31, Issue:2 Topics: Analgesics, Opioid; Animals; Anti-Infective Agents; Azaperone; Biopsy; Butorphanol; Dinoprost; Dinoprostone; Female; Hypnotics and Sedatives; Hysteroscopy; Laparoscopy; Naltrexone; Perissodactyla; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography; Uterus; Vulva	2000
The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain research, 2001, Aug-03, Volume: 909, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Butorphanol; Drug Interactions; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Deprivation; Guanidines; Male; Morphinans; Naltrexone; Narcotic Antagonists; Narcotics; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa	2001
Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Pharmacology, biochemistry, and behavior, 2002, Volume: 74, Issue:1 Topics: Animals; Basal Ganglia; Butorphanol; Diffusion; Electric Stimulation; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome	2002
Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC pharmacology, 2003, Jan-04, Volume: 3 Topics: Azocines; beta-Endorphin; Binding, Competitive; Butorphanol; Cell Line; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Fentanyl; Humans; Hydromorphone; Ligands; Morphine; Naltrexone; Phenazocine; Radioligand Assay; Receptors, Opioid, mu; Tritium	2003
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats. Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:1 Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination	2003
Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol. Journal of neuroscience research, 2003, Jun-15, Volume: 72, Issue:6 Topics: Animals; Brain; Butorphanol; Dose-Response Relationship, Drug; Male; Naltrexone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders	2003
Reversible anesthesia of captive California sea lions (Zalophus californianus) with medetomidine, midazolam, butorphanol, and isoflurane. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2004, Volume: 35, Issue:1 Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antidotes; Butorphanol; Dose-Response Relationship, Drug; Female; Flumazenil; Heart Rate; Hypnotics and Sedatives; Imidazoles; Immobilization; Isoflurane; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Sea Lions; Time Factors	2004
Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline. Behavioural pharmacology, 2011, Volume: 22, Issue:5-6 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Morphine; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reinforcement Schedule; Sodium Chloride	2011
[Model of platelet activation as experimental test system for screening kappa-opioid receptor ligands]. Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:8 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Benzimidazoles; Blood Platelets; Butorphanol; High-Throughput Screening Assays; Ligands; Light; Naltrexone; Platelet Activation; Rabbits; Receptors, Opioid, kappa; Scattering, Radiation	2011
[Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205]. Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:9 Topics: Analgesics; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Male; Mice; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Pain; Pain Measurement; Rats; Receptors, Opioid, kappa	2013
Injection Butorphanol dependence: A case report. Asian journal of psychiatry, 2018, Volume: 35 Topics: Adult; Analgesics, Opioid; Buprenorphine; Butorphanol; GABA Modulators; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nitrazepam; Opiate Substitution Treatment; Opioid-Related Disorders	2018
Tissue Residue Levels of the Tranquilizer Combination of Butorphanol, Azaperone, and Medetomidine, and the Antagonists, Naltrexone, Atipamezole, and Tolazoline, in Black Bears (Ursus americanus) Postimmobilization. Journal of wildlife diseases, 2020, 10-01, Volume: 56, Issue:4 Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Antihypertensive Agents; Azaperone; Butorphanol; Drug Combinations; Drug Residues; Hypnotics and Sedatives; Imidazoles; Immobilization; Medetomidine; Naltrexone; Narcotic Antagonists; Tolazoline; Ursidae	2020
Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol. Journal of the South African Veterinary Association, 2021, May-21, Volume: 92, Issue:0 Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Butorphanol; Conscious Sedation; Drug Combinations; Fur Seals; Hypnotics and Sedatives; Imidazoles; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists	2021